Monday, 19 August 2019

Pharmaceutical microbiology: current and future challenges


On 15th October 2018 Tim Sandle delivered the key note address to the PDA Microbiology Europe conference. Tim Sandle has written an article which takes the form of an edited transcript of the presentation.

Whilst there is a continuing need for monitoring of the environment and conducting standardized laboratory tests, pharmaceutical microbiology has moved on to embrace:
  • Microbiological audits;
  • Rapid microbiological methods;
  • Conducting risk assessments, both proactive in terms of minimizing contamination and reactive, in terms of addressing microbial data deviations;
  • Ensuring that processes meet ‘quality by design’ principles;
  • And getting the microbiologist away from the bench and into the plant.

These themes are captured in the auricle, for which the reference is:

Sandle, T. (2019) Pharmaceutical microbiology: current and future challenges, Pharmig News, Issue 75, pp12-15

For details, please contact Tim Sandle

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers